• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

持续非卧床腹膜透析对尿毒症患者贫血的影响。

Effect of continuous ambulatory peritoneal dialysis on anemia in uremic patients.

作者信息

Marcovici O, Boner G, Rosenfeld J B

出版信息

Isr J Med Sci. 1983 Jul;19(7):604-7.

PMID:6885343
Abstract

The effect of continuous ambulatory peritoneal dialysis (CAPD) on anemia was examined in 10 patients over a period of 6 mo. The mean hemoglobin levels in these patients did not change during this period and were not different from those of a group of 10 patients on hemodialysis. There were no changes in serum iron, iron saturation, serum haptoglobin, serum parathyroid hormone and red cell survival during this period. There was an inverse correlation between serum ferritin and hemoglobin levels. These studies show that CAPD is not associated with an improvement in anemia of uremic patients. Previous report on improvement in anemia most likely reflected the smaller loss of blood during CAPD compared with hemodialysis.

摘要

在6个月的时间里,对10例患者进行了持续性非卧床腹膜透析(CAPD)对贫血影响的研究。在此期间,这些患者的平均血红蛋白水平没有变化,且与一组接受血液透析的10例患者的血红蛋白水平没有差异。在此期间,血清铁、铁饱和度、血清触珠蛋白、血清甲状旁腺激素和红细胞存活率均无变化。血清铁蛋白与血红蛋白水平呈负相关。这些研究表明,CAPD与改善尿毒症患者的贫血无关。先前关于贫血改善的报告很可能反映了与血液透析相比,CAPD期间失血较少。

相似文献

1
Effect of continuous ambulatory peritoneal dialysis on anemia in uremic patients.持续非卧床腹膜透析对尿毒症患者贫血的影响。
Isr J Med Sci. 1983 Jul;19(7):604-7.
2
Loss of phospholipids asymmetry in red blood cells contributes to anemia in uremic patients.红细胞中磷脂不对称性的丧失导致尿毒症患者贫血。
Adv Perit Dial. 2001;17:58-60.
3
Parathyroid hormone contributes to variations in blood morphology in diabetic and non diabetic patients treated with continuous ambulatory peritoneal dialysis.甲状旁腺激素在接受持续性非卧床腹膜透析治疗的糖尿病和非糖尿病患者中,对血液形态变化有影响。
Adv Perit Dial. 2001;17:5-9.
4
[Anemia in patients on continuous ambulatory peritoneal dialysis (CAPD)].
Fukuoka Igaku Zasshi. 1989 Jul;80(7):379-84.
5
[The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].[血液透析和持续性非卧床腹膜透析对肾性贫血的影响]
Srp Arh Celok Lek. 1997 May-Jun;125(5-6):163-7.
6
Improved response to erythropoietin in peritoneal dialysis patients as compared to hemodialysis patients: role of iron deficiency.与血液透析患者相比,腹膜透析患者对促红细胞生成素的反应改善:缺铁的作用。
Adv Perit Dial. 1994;10:135-8.
7
What happens after conversion of treatment to continuous ambulatory peritoneal dialysis from hemodialysis?从血液透析转为持续性非卧床腹膜透析后会发生什么?
Adv Perit Dial. 2000;16:177-81.
8
Potential role of parathyroid hormone as an inhibitor of erythropoiesis in the anemia of renal failure.甲状旁腺激素在肾衰竭贫血中作为红细胞生成抑制剂的潜在作用。
J Lab Clin Med. 1984 Dec;104(6):1016-26.
9
Comparative effects of erythropoietin with oral iron in peritoneal dialysis and hemodialysis patients.促红细胞生成素与口服铁剂对腹膜透析和血液透析患者的比较效果
Adv Perit Dial. 1993;9:177-80.
10
The role of erythrocytes phosphatidylserine exposure in anemia in peritoneal dialysis patients.
Ren Fail. 2006;28(7):573-6. doi: 10.1080/08860220600839647.